QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CVR PartnersEvogeneMarrone Bio InnovationsWynnstay Group Plc (WYN.L)Calyxt
SymbolNYSE:UANNASDAQ:EVGNNASDAQ:MBIILON:WYNNASDAQ:CLXT
Price Information
Current Price$26.80$6.70$2.50GBX 480$10.26
52 Week RangeN/ABuyBuyN/AHold
MarketRank™
Overall Score0.51.31.11.20.9
Analysis Score0.03.52.50.01.2
Community Score2.02.32.32.32.5
Dividend Score0.00.00.01.70.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.60.60.61.90.6
Analyst Ratings
Consensus RecommendationN/ABuyBuyN/AHold
Consensus Price TargetN/A$9.00$2.81N/A$9.00
% Upside from Price TargetN/A34.33% upside12.50% upsideN/A-12.28% downside
Trade Information
Market Cap$297.45 million$172.53 million$418.70 million£96.25 million$380.29 million
Beta1.841.430.22N/A2.36
Average Volume36,2772,093,791845,02686,882399,877
Sales & Book Value
Annual Revenue$404.18 million$750,000.00$29.37 million£431.40 million$7.30 million
Price / Sales0.74230.0314.260.2252.09
Cashflow$6.84 per shareN/AN/AGBX 100.95 per shareN/A
Price / Cash3.92N/AN/A4.75N/A
Book Value$37.03 per share$2.34 per share$0.18 per shareGBX 490.70 per share$1.90 per share
Price / Book0.722.8613.890.015.40
Profitability
Net Income$-34,970,000.00$-18,110,000.00$-37,170,000.00N/A$-39,610,000.00
EPSN/A($0.70)($0.21)GBX 27.60($1.21)
Trailing P/E RatioN/AN/AN/A17.39N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-30.71%-2,649.69%-69.75%N/A-318.57%
Return on Equity (ROE)-17.27%-38.40%-91.71%N/A-89.86%
Return on Assets (ROA)-5.98%-32.43%-29.59%N/A-58.95%
Dividend
Annual PayoutN/AN/AN/AGBX 0.14N/A
Dividend YieldN/AN/AN/A0.03%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A0.51%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.88%N/A0.81%11.78%0.56%
Current Ratio1.69%9.78%1.05%1.96%4.83%
Quick Ratio1.02%9.78%0.78%1.30%4.08%
Ownership Information
Institutional Ownership PercentageN/A32.98%34.47%N/A23.81%
Insider Ownership PercentageN/AN/A4.67%N/A2.30%
Miscellaneous
Employees28614313397875
Shares Outstanding11.10 million25.75 million167.48 million20.05 million37.07 million
Next Earnings Date5/5/2021 (Estimated)3/3/2021 (Confirmed)3/11/2021 (Estimated)N/A3/4/2021 (Confirmed)
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.